Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2014, vol. 23, nr 3, May-June, p. 381–394

Publication type: original article

Language: English

The Dynamics of Respiratory Muscle Changes During the Progression of Chronic Obstructive Pulmonary Disease

Aleksander E. Makarevich1,A,C,D,E,F,G, Svetlana S. Lemiasheuskaya1,A,B,C,D,E,F, Aleksander J. Poctavcev1,A,C,E,F, Aleksander I. Lemeschewskij2,B,C,D,E,F, Michail Nedvedz3,C,E,F

1 Department of Internal Medicine, Belarusian State Medical University, Minsk, Belarus

2 Department of general Surgery, Belarusian State Medical University, Minsk, Belarus

3 Department of Pathologic Anatomy, Belarusian State Medical University, Minsk, Belarus

Abstract

Background. Pathological changes of the respiratory muscles (RM) during the development of chronic obstructive pulmonary disease (cOPD) have not yet been studied in detail.
Objectives. The aim of the research was to assess RM status in cOPD and the relationship between echodensitometric and morphological changes in the RM.
Material and Methods. The participants – 152 male cOPD patients – were divided into three groups according to the severity of the disease: cOPD1 (mild), cOPD2 (moderate) and cOPD3 (severe). The status of the accessory RM in these groups was investigated using echodensitometry indices (echogenicity: IE; homogeneity: IH; and structural density: ISD) and the morphological material of the abdominal internal oblique muscle in 25 patients with cOPD1 and cOPD2.
Results. considerable differences among the cOPD groups were revealed. In mild cOPD a tendency toward increased homogeneity was detected (due to RM hypertrophy), while echogenicity results varied. IH and ISD decreased in moderate cOPD, while IE was increased due to RM fatty infiltration and sclerosis (according to the morphological data). In severe cOPD, IH and ISD rose again against a background of IE decrease. The presence of myolysis, sclerotic changes and contractures of myofibrils in the RM was significantly more frequently observed in cOPD1 and cOPD2 compared with the controls (where these features were rare). The sensitivity and specificity of the morphological and ultrasonic methods were similar in assessing atrophic and sclerotic RM changes, while their accuracy was lower in analyzing other morphological signs.
Conclusion. The echodensitometric parameters investigated reflect, in a complex way, different dynamics of degenerative RM processes during the progression of cOPD.

Key words

chronic obstructive pulmonary disease, sarcopenia, respiratory muscles, ultrasonic densitometry.

References (39)

  1. Franssen FM: Sarcopenia in cOPD: functional and metabolic implications. Eds.: Schols A., Wouters E. Maastricht University 2009, 248.
  2. Bezdenezhnykh AV, Sumin AN: Sarcopenia: prevalence, detection, clinical significance. clin Med (Russia) 2012, 10, 16–22.
  3. Cesari M, Pahor M, Lauretani F: Skeletal muscle and mortality results. In cHIANTI Study. J gerontol 2009, 64A, 377–384.
  4. Santanasto AJ, Glynn NW, Newman MA: Impact of weight loss on physical function with changes in strength, muscle mass, and muscle fat infiltration in overweight to moderately obese older adults: A randomized clinical trial. J. Obesity 2011, article ID 516576, doi:10.1155/2011/516576.
  5. Stenholm S, Harris TB, Rantanen T: Sarcopenic obesity: definition, cause and consequences. curr Opin clin Nutr Metab care 2008, 693–700.
  6. Agusti AG: Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003, 21, 347–360.
  7. Fitting JW: Respiratory muscles in chronic obstructive pulmonary disease. Swiss Medical Weekly 2001, 131, 483–486.
  8. Avdeev SN: cOPD as systemic disease. Pulmonology (Russia) 2007, 2, 104–116.
  9. Garcia-Rio F: Daily physical activity in patients with cOPD is mainly associated with dynamic hyperinflation. Am J Respir crit care Med 2009, 180, 506–512.
  10. Watz H: Physical activity in patients with cOPD. Eur Respir J 2009, 33, 262–272.
  11. Watz H: Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir crit care Med 2008, 177, 743–751.
  12. Waschki B: Physical activity is the strongest predictor of all-cause mortality in patients with cOPD. chest 2011, 140, 331–359.
  13. Perzeva TA: Muscle’s dysfunction in cOPD: overestimate of this problem, new possibilities of therapy. Health of Ukraine (electronic resource) 2008.
  14. Bernarg S: Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir crit care Med 1998, 158, 629–634.
  15. Sharp JT: The respiratory muscles in cOPD. Am Rev Respir Dis 1986, 134, 1089–1091.
  16. O’Donnell DE, Laveneziana P: Physiology and consequences of lung hyperinflation in cOPD. Eur Respir Rev 2006, 15, 61–67.
  17. Avdeev SN: Pulmonary hyperinflation in cOPD patients. Pulmonol Allergol (Russia) 2006, 2, 11–16.
  18. Laghi F: Disorders of the respiratory muscles. Am J Respir crit care Med 2003, 168, 10–48.
  19. Chuchalin AG, Ajsanov ZR: Disorders of respiratory muscles function in cOPD. Therap. Archive (Russia) 1988, 8, 126–132.
  20. Surkova EG: The estimation of diaphragm function in cOPD according to the data of ultrasound methods. In: Scientific proceedings of St.-Petersburg Academy. Ed.: Jaickij NA, St-Petersburg (Russia) 2009, 16, 28–32.
  21. Similowski T, Yan S, Gauthier AP: contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med 1991, 325, 917–923
  22. Orozco-Levi M, Gea J, Lloreta JL: Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 1999, 13, 371–378.
  23. Levine S, Kaiser L, Leferovich J, Tikunov B: cellular adaptations in the diaphgram in chronic obstructive pulmonary disease. N Engl J Med 1997, 337, 1799–1806.
  24. Mercadier JJ, Schwarz K, Schiaffino S: Myosin heavy chain gene expression changes in the diaphragm of patient with chronic lung hyperinflation. Am J Physiol 1998, 274, 527–534.
  25. Orozco-Levi M: Structure and function of the respiratory muscles in patients with cOPD: impairment or adaptation? Eur Respir J 2003, 22, Suppl. 46, 41–51.
  26. Cullen MJ: Morphological changes in dystrophic muscle. british Medical bulletin 1980, 36, 145–152.
  27. Jobin J, Maltais F, Doyon JF: chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J cardiopulm Rehabil 1998, 18, 432–437.
  28. Petrella JK, Kim JS, Tuggle SC: Age differences in knee extension power, contractile velocity, and fatigability. J Appl Physiol 2005, 98, 211–220.
  29. Schertzer JD, Van der Poel C, Shavlakadze T: Muscle-specific overexpression of Igf-I improves E-c coupling in skeletal muscle fibers from dystrophic mice. Am J Physiol cell Physiol 2008, 294, 161–168.
  30. Ambrosimov VN: Dysfunction of respiratory muscles and their diagnostics in cOPD patients. clin gerontology (Russia) 2008, 6, 38–43.
  31. Wouters EF: Nonpharmacological modulation of dynamic hyperinflation. Eur Respir Rev 2006, 15, 90–95.
  32. Casaburi R, Bhasin S, Cosentino L: Effects of testosterone and resistance training in men with chronic obstructive disease. Am J Respir crit care Med 2004, 170, 870–878.
  33. Casaburi R: Impacting patient-centered outcomes in cOPD: deconditioning. Eur Respir Rev 2006, 15, 42–46.
  34. Tkác J: Systemic consequences of cOPD. Therap Advances in Respir Dis 2007, 1, 47–59.
  35. Van Eeden SF, Sin DD: cOPD: A chronic Systemic Inflammatory Disease. Respiration 2008, 75, 224–238.
  36. Mador MJ, Bozkanat E: Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respiratory Research 2001, 2, 216–224.
  37. Shrikrishna D: Ultrasound measurement of quadriceps wasting in patients with gOLD stage II cOPD and its relationship to physical activity. Eur Respir J (Abstracts; 21th ERS annual congress), Amsterdam, Netherlands 2011, 38, Suppl. 55, 889.
  38. Platonova IS: The morphologic changes of respiratory muscles in cOPD patients with different degree of respiratory insufficiency. Author’s abstract of dissertation on scientific degree of candidate of medical sciences. St.-Petersburg Med. University, St.-Petersburg (Russia), 2003, 18.
  39. Global Initiative for chronic Obstructive Pulmonary Disease (gOLD). global Strategy for the Diagnosis, Management, and Prevention of chronic Obstructive Pulmonary Disease, global Initiative for chronic Obstructive Lung Disease NHLbI/WHO workshop report. Last updated 2011. http://www.goldcopd.org.
© Wroclaw Medical University